openPR Logo
Press release


04-10-2017 05:13 PM CET | Health & Medicine

Press release from: Medical Device Report By CMI


Oxygen Concentrators – A Breath of Fresh Air

Until recently, oxygen cylinders was the gold standard method for oxygen delivery to patients with chronic respiratory disorders or hypoxia. In the last few years, oxygen concentrators has emerged as a more convenient alternative to the cumbersome to use and transport oxygen cylinders. Development in the technology of oxygen concentrators has further supported preference for this device as compared to oxygen cylinders. Increasing inclination of patients towards home therapy in turn is increasing prescription for home use oxygen concentrators. Furthermore, with the continuous and pulse mode of oxygen supply, users can set their preferences and have the desired rate of oxygen supply.

As the device use ambient air for the supply of oxygen, it is much cost effective and safer to use than pressurized oxygen cylinders. The oxygen concentrators market has emerged from nothing to millions in revenue in just few years. Patient can use static oxygen concentrators or portable oxygen concentrators or refill the cylinders using their static oxygen concentrators for ambulatory use. Convenience is where the oxygen concentrators market has gained significant attention and increasing traction from patients with respiratory disorders. Novel wearable devices that will monitor the oxygen levels in patient’s body and when required, the device will deliver required amount of oxygen are no distant dreams now.

Request a sample copy of this report @

The global oxygen concentrators market was valued at US$ 930.2 million in 2015 and is expected to witness a CAGR of 7.4% during the forecast period (2016 – 2024).

Increasing Product Competitiveness

Market players are competing based on pricing and features, which is now extended to technology. More compact and lightweight oxygen concentrators are being made available in the market. Furthermore, devices with different oxygen supplying capacities are also introduced to target specific demands of users. Devices specific for pediatric patients are now available, which have low flow-rate making them ideal for hospital environments and also home use. In addition, devices with pulse as well as continuous flow mode are now available to eliminate the need to purchase two separate devices. Furthermore, oxygen concentrators are now digitally connected to monitor and ensure efficient functioning of the system. USB connection and cloud-based network connection are a few advancements in the technology. Such product developments and innovations would be favorable for consistent growth of the global oxygen concentrators market.

Digital transformation to underpin the growth of oxygen concentrators market

The global healthcare sector is undergoing a wave of transformation, with digitization being the core focus area of product manufacturers and service providers. Healthcare IT products and systems are in high demand in emerging nations such as India, China, Brazil, Indonesia, and also Israel, as part of the ongoing upgrade of healthcare infrastructure in these countries.Considering the future dynamics in the healthcare industry, manufacturers of oxygen concentrators are also trying to integrate IT with the devices. This is expected to propel growth of oxygen concentrators market in these regions. Oxilife Independence by O2 Concepts LLC is connected on cloud network for the manufacturer/service provider to monitor functioning of the device and provide any upgrade to the system software. This technology aids in ensuring optimal performance of the battery operated oxygen concentrators. Oxilife Independence is the world’s first smart oxygen concentrator.

Request for Customization @

COPD incidence acting as the growth propeller for the oxygen concentrators market

Aging population and heightened risk to respiratory disorders would favor growth of oxygen concentrators market in future. Chronic obstructive respiratory disorders (COPD) is the major target or user population of oxygen concentrators market. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is estimated to cause 3 million deaths globally in 2015.

• Around 1.2 million people in the U.K. were diagnosed with COPD, accounting for nearly 2% of the country’s population (British Lung foundation, 2016). A large part of the population remains undiagnosed.

• COPD affects 30 million population in the U.S., which accounts for nearly 6.3% of the total U.S. population (COPD Foundation, 2013)

• COPD is more common in the people above 40 years of age

• COPD prevalence in Asia Pacific region was found to be 6.2% in 2015 (Study published in Asia Pacific Family Medicine journal)

Click here to know more about this report @

Only a few percentage of these patients are prescribed oxygen concentrators implying the huge potential for the market players. Creating more awareness, especially in emerging economies would augment the demand for oxygen concentrators. A collaborative approach among the companies, government and insurance companies would benefit the industry and help save a lot to the patients and insurance reimbursement providers.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit Coherent Market Insights Blog @
Connect with us on LinkedIn @

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OXYGEN CONCENTRATORS MARKET SIZE TO REACH CLOSE TO US$ 2 BILLION BY 2024 here

News-ID: 497469 • Views: 282

More Releases from Medical Device Report By CMI

Rising Innovative Therapies Is Expected To Foster Growth Of The Osteoporosis Tre …
Pigmented lesion is a skin disease usually referred to as melanocytic proliferations. Pigmented lesions are brown, black or blue in color, due to melanin, blood, or exogenous pigment. Spreading or growing lesions, pigmented lesions on exposed skin can be a symptom of skin cancer. Pigmented lesion are classified as non-melanocytic lesions and melanocytic lesions, and further classified as benign and malignant. Malignant lesion is a tissue, which appears abnormal under
Precision Medicine Market
Precision medicine is an approach of treatment that has been derived on the basis of individual variability in environment, genes and lifestyle of each person. This novel approach assists medical practitioners and researchers to understand various treatment needs in order to prevent specific diseases. It allows for highly precise targeting of medication for treatment of various diseases, which is expected to lead to high adoption by medical practitioners and researchers.
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Venipuncture Needle and Syringes Market — Global Industry Insights, Trends and …
Venipuncture is a perforation on a vein as part of a medical practice, basically to draw a blood sample and or to inject a drug into the body. This is done by intravenous cannulation. The venipuncture blood collection is carried out with the help of needle and syringes. Venipuncture is the oldest invasive procedures, which is carried out for five basic reasons and they are to collect blood for investigative

All 5 Releases

More Releases for COPD

COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the